Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -1.8x - -1.9x | -1.8x |
| Selected Fwd P/E Multiple | -1.8x - -1.9x | -1.8x |
| Fair Value | ¥1.03 - ¥1.14 | ¥1.09 |
| Upside | 12.3% - 24.1% | 18.2% |
| Benchmarks | - | Full Ticker |
| Sinotherapeutics Inc. | 68,824,700.0% | SHSE:688247 |
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 30,002,600.0% | SZSE:300026 |
| Luye Pharma Group Ltd. | 218,600.0% | SEHK:2186 |
| Hubei Guangji Pharmaceutical Co., Ltd. | 95,200.0% | SZSE:000952 |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 60,067,100.0% | SHSE:600671 |
| Ji Yao Holding Group Co., Ltd. | 30,010,800.0% | SZSE:300108 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| 688247 | 300026 | 2186 | 952 | 600671 | 300108 | |||
| SHSE:688247 | SZSE:300026 | SEHK:2186 | SZSE:000952 | SHSE:600671 | SZSE:300108 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 94.2% | -33.8% | -16.4% | NM- | NM- | NM- | ||
| 3Y CAGR | -1.7% | -58.0% | -9.0% | NM- | NM- | NM- | ||
| Latest Twelve Months | 110.0% | -89.9% | 68.3% | -534.3% | 77.6% | -289.6% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 33.7% | 7.5% | 9.8% | 0.5% | -27.3% | -112.3% | ||
| Prior Fiscal Year | 20.4% | 8.3% | 10.1% | 6.3% | -62.0% | -56.4% | ||
| Latest Fiscal Year | 25.0% | 0.9% | 8.7% | -19.0% | -31.4% | -100.9% | ||
| Latest Twelve Months | 25.0% | 0.9% | 12.2% | -34.2% | -9.1% | -120.3% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 25.4x | 29.8x | 5.7x | -66.0x | -230.7x | -10.2x | ||
| Price / LTM Sales | 9.4x | 1.8x | 1.4x | 2.9x | 8.6x | 1.7x | ||
| LTM P/E Ratio | 37.6x | 209.5x | 11.3x | -8.5x | -95.1x | -1.4x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -95.1x | 11.3x | 209.5x | |||||
| Historical LTM P/E Ratio | -19.3x | -2.9x | 20.6x | |||||
| Selected P/E Multiple | -1.8x | -1.8x | -1.9x | |||||
| (x) LTM Net Income | (436) | (436) | (436) | |||||
| (=) Equity Value | 764 | 804 | 844 | |||||
| (/) Shares Outstanding | 666.0 | 666.0 | 666.0 | |||||
| Implied Value Range | 1.15 | 1.21 | 1.27 | |||||
| FX Rate: CNY/CNY | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 1.15 | 1.21 | 1.27 | 0.92 | ||||
| Upside / (Downside) | 24.7% | 31.2% | 37.8% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 688247 | 300026 | 2186 | 952 | 600671 | 300108 | |
| Value of Common Equity | 4,827 | 10,695 | 8,699 | 1,973 | 1,380 | 613 | |
| (/) Shares Outstanding | 449.0 | 3,004.2 | 3,761.7 | 349.9 | 121.8 | 666.0 | |
| Implied Stock Price | 10.75 | 3.56 | 2.31 | 5.64 | 11.33 | 0.92 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 0.93 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 10.75 | 3.56 | 2.48 | 5.64 | 11.33 | 0.92 | |
| Trading Currency | CNY | CNY | HKD | CNY | CNY | CNY | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 0.93 | 1.00 | 1.00 | 1.00 | |